Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Director departure
Credit agrmnt [a]
|
|
Gossamer Bio, Inc. (GOSS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/21/2023 |
DEL AM
| Form DEL AM - Delaying amendment: |
| 08/18/2023 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 08/18/2023 |
RW
| Form RW - Registration Withdrawal Request: |
| 08/17/2023 |
S-3ASR
| Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers: |
| 08/08/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/08/2023 |
8-K
| Quarterly results |
| 08/07/2023 |
D
| Form D - Notice of Exempt Offering of Securities: |
| 07/28/2023 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2023 |
8-K
| Quarterly results |
| 07/20/2023 |
8-K
| Quarterly results |
| 06/09/2023 |
4
| GALA RENEE D (Director) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Granted 35,000 options to buy
@ $1.26, valued at
$44.1k
|
|
| 06/09/2023 |
4
| Cox Russell J. (Director) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Granted 35,000 options to buy
@ $1.26, valued at
$44.1k
|
|
| 06/09/2023 |
4
| Milligan Sandra (Director) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Granted 35,000 options to buy
@ $1.26, valued at
$44.1k
|
|
| 06/09/2023 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders... |
| 06/09/2023 |
4
| Daniel Thomas O (Director) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Granted 35,000 options to buy
@ $1.26, valued at
$44.1k
|
|
| 06/09/2023 |
4
| Burow Kristina (Director) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Granted 35,000 options to buy
@ $1.26, valued at
$44.1k
|
|
| 05/10/2023 |
SC 13G/A
| STATE STREET CORP reports a 1.4% stake in EXIT FILING GOSSAMER BIO INC |
| 05/09/2023 |
4
| Peterson Caryn (EVP, Regulatory Affairs) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Disposed/sold 48,500 options to buy
@ $22.1, valued at
$1.1M
Disposed/sold 13,750 options to buy
@ $16.4, valued at
$225.5k
Disposed/sold 34,175 options to buy
@ $14.55, valued at
$497.2k
Disposed/sold 28,250 options to buy
@ $9.79, valued at
$276.6k
Disposed/sold 31,750 options to buy
@ $8.49, valued at
$269.6k
Disposed/sold 190,000 options to buy
@ $11.94, valued at
$2.3M
Granted 32,334 options to buy
@ $0
Granted 9,167 options to buy
@ $0
Granted 22,784 options to buy
@ $0
Granted 18,834 options to buy
@ $0
Granted 21,167 options to buy
@ $0 |
|
| 05/09/2023 |
4
| Aranda Richard (Chief Medical Officer) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Disposed/sold 45,000 options to buy
@ $22.1, valued at
$994.5k
Disposed/sold 13,750 options to buy
@ $16.4, valued at
$225.5k
Disposed/sold 34,175 options to buy
@ $14.55, valued at
$497.2k
Disposed/sold 60,000 options to buy
@ $9.79, valued at
$587.4k
Disposed/sold 30,000 options to buy
@ $8.47, valued at
$254.1k
Disposed/sold 190,000 options to buy
@ $11.94, valued at
$2.3M
Granted 30,000 options to buy
@ $0
Granted 9,167 options to buy
@ $0
Granted 22,784 options to buy
@ $0
Granted 40,000 options to buy
@ $0
Granted 20,000 options to buy
@ $0 |
|
| 05/09/2023 |
4
| Christian Waage (EVP, Tech Ops and Admin) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Disposed/sold 105,000 options to buy
@ $22.1, valued at
$2.3M
Disposed/sold 71,500 options to buy
@ $14.55, valued at
$1M
Disposed/sold 90,000 options to buy
@ $9.79, valued at
$881.1k
Disposed/sold 190,000 options to buy
@ $11.94, valued at
$2.3M
Granted 70,000 options to buy
@ $0
Granted 47,667 options to buy
@ $0
Granted 60,000 options to buy
@ $0
Granted 126,667 options to buy
@ $0 |
|
| 05/09/2023 |
4
| Giraudo Bryan (COO/CFO) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Disposed/sold 145,000 options to buy
@ $22.1, valued at
$3.2M
Disposed/sold 71,500 options to buy
@ $14.55, valued at
$1M
Disposed/sold 90,000 options to buy
@ $9.79, valued at
$881.1k
Disposed/sold 150,000 options to buy
@ $10.54, valued at
$1.6M
Disposed/sold 265,000 options to buy
@ $11.94, valued at
$3.2M
Granted 96,667 options to buy
@ $0
Granted 47,667 options to buy
@ $0
Granted 60,000 options to buy
@ $0
Granted 100,000 options to buy
@ $0
Granted 176,667 options to buy
@ $0 |
|
| 05/09/2023 |
4
| Hasnain Faheem (President & CEO) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Granted 750,000 options to buy
@ $1.36, valued at
$1M
|
|
| 05/09/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 05/09/2023 |
8-K
| Quarterly results |
| 05/09/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/05/2023 |
SC 13G/A
| BlackRock Inc. reports a 4.9% stake in GOSSAMER BIO, INC. |
| 04/17/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 04/05/2023 |
4
| Giraudo Bryan (COO/CFO) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Bought 55,000 shares
@ $1.0199, valued at
$56.1k
|
|
| 04/03/2023 |
8-K
| Other Events Interactive Data |
| 03/22/2023 |
4
| Carter Laura (Chief Scientific Officer) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Granted 157,500 options to buy
@ $1.21, valued at
$190.6k
|
|
| 03/22/2023 |
4
| Peterson Caryn (EVP, Regulatory Affairs) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Granted 157,500 options to buy
@ $1.21, valued at
$190.6k
|
|
|
|
|